The tumor microenvironment is a dominant force in multidrug resistance.

The tumor microenvironment is a dominant force in multidrug resistance.
复制标题

DOI:
10.1016/j.drup.2012.01.006
复制
发表时间:
2012-02
影响因子:
24.3
通讯作者:
Bissell, Mina J.
Bissell, Mina J.
中科院分区:
医学1区
文献类型:
--
作者:
Correia, Ana Luisa;Bissell, Mina J.

文献摘要

参考文献

被引文献

相似文献

临床耐药性的出现仍然是影响癌症治疗效果的最具挑战性的因素之一。直到最近,假设随机遗传病变足以解释恶性肿瘤的进展和逃避化疗。在这里,我们提出了一个额外的观点,其中肿瘤细胞,尽管恶性基因组可以找到一个微环境,无论是在肿瘤内或作为一个休眠细胞保持极性和融入一个有组织的背景。靶向这种动态相互作用可以被认为是预防治疗耐药性的新途径,甚至可能提供有希望的有效癌症治疗。
The emergence of clinical drug resistance is still one of the most challenging factors in cancer treatment effectiveness. Until more recently, the assumption has been that random genetic lesions are sufficient to explain the progression of malignancy and escape from chemotherapy. Here we propose an additional perspective, one in which the tumor cells despite the malignant genome could find a microenvironment either within the tumor or as a dormant cell to remain polar and blend into an organized context. Targeting this dynamic interplay could be considered a new avenue to prevent therapeutic resistance, and may even provide a promising effective cancer treatment.
DOI: 10.1016/j.cell.2010.05.029
发表时间: 2010-07-09
期刊: Cell
影响因子: 64.5
作者:
Cao L;Liu X;Lin EJ;Wang C;Choi EY;Riban V;Lin B;During MJ
通讯作者: During MJ
DOI: 10.1182/blood.v93.5.1658
发表时间: 1999-03-01
期刊: BLOOD
影响因子: 20.3
作者:
Damiano, JS;Cress, AE;Dalton, WS
通讯作者: Dalton, WS
DOI: 10.1073/pnas.0337599100
发表时间: 2003-02-18
影响因子: 11.1
作者:
Anders, M;Hansen, R;Korn, WM
通讯作者: Korn, WM
DOI: 10.1038/sj.onc.1204554
发表时间: 2001-08-16
期刊: ONCOGENE
影响因子: 8
作者:
Aoudjit, F;Vuori, K
通讯作者: Vuori, K
DOI: 10.1158/0008-5472.can-10-0591
发表时间: 2010-08-01
期刊: Cancer research
影响因子: 11.2
作者:
Bussard KM;Boulanger CA;Booth BW;Bruno RD;Smith GH
通讯作者: Smith GH